Investors & Media

Ionis announces the appointment of Michael Yang to Board of Directors

CARLSBAD, Calif. , Dec. 14, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the appointment of Michael Yang , an experienced biopharmaceutical executive, to the Ionis Board of Directors. Mr. Yang’s appointment expands the total number of Ionis Board members to 10.

Read more
You are now leaving https://www.ionispharma.com to visit